Asset Details
Do you wish to reserve the book?
Baicalin enhances respiratory mucosal immunity by modulating antiviral protein expression and T-cell homeostasis during H9N2 infection
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Baicalin enhances respiratory mucosal immunity by modulating antiviral protein expression and T-cell homeostasis during H9N2 infection
Do you wish to request the book?
Baicalin enhances respiratory mucosal immunity by modulating antiviral protein expression and T-cell homeostasis during H9N2 infection
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Baicalin enhances respiratory mucosal immunity by modulating antiviral protein expression and T-cell homeostasis during H9N2 infection
2025
Overview
The H9N2 avian influenza virus, although not highly pathogenic, still poses ongoing risks to poultry health and food security due to its ability to resist vaccines and its potential to spread to humans.
This study investigated the effects of baicalin, a flavonoid derived from
, on respiratory mucosal immunity during H9N2 infection. In vitro experiments were conducted using MLE-12 alveolar epithelial cells, and in vivo evaluations were performed in a mouse model of H9N2 infection.
Baicalin treatment enhanced the expression of antiviral proteins Mx1 and PKR in a dose- and time-dependent manner, helping to counteract the virus's suppression of these defense proteins. In addition to strengthening this epithelial barrier, baicalin has both antiviral and immune-regulating effects: it directly blocks viral replication and helps restore the CD4+/CD8+ T cell ratio in H9N2-infected mice. Most importantly, baicalin reduces lung damage and spleen shrinkage while keeping the immune system balanced. These results show that baicalin enhances mucosal antiviral defenses by simultaneously regulating innate antiviral pathways (Mx1 and PKR) and restoring adaptive immune balance (CD4+/CD8+ T-cell ratio).
These dual protective effects highlight baicalin's potential as a natural therapeutic strategy for improving mucosal immunity against vaccine-resistant influenza viruses such as H9N2, contributing valuable insights into plant-derived immunomodulatory approaches against emerging zoonotic viral threats.
Publisher
Frontiers Media SA,Frontiers Media S.A
Subject
/ Alveoli
/ Animals
/ Antiviral Agents - pharmacology
/ Baicalin
/ Cells
/ Female
/ Humans
/ Immunity, Mucosal - drug effects
/ Influenza A Virus, H9N2 Subtype - drug effects
/ Influenza A Virus, H9N2 Subtype - immunology
/ Mice
/ MX1
/ Myxovirus resistance proteins
/ Orthomyxoviridae Infections - drug therapy
/ Orthomyxoviridae Infections - immunology
/ Orthomyxoviridae Infections - virology
/ PKR
/ Respiratory Mucosa - drug effects
/ Respiratory Mucosa - immunology
/ respiratory mucosal immunity
/ T-Lymphocytes - drug effects
/ Vaccines
/ Virus Replication - drug effects
/ Viruses
